Metraipolis › archive › dc_de674c8ee6f7
Asparagine endopeptidase (AEP) inhibitor formulation via zein-based nanoparticle improves the therapeutic efficacy toward Alzheimer's disease — Europe PMC PMID:40816999
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40816999
- DOI
- 10.1016/j.neurot.2025.e00718
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T15:03:41.410Z
- SHA-256 of the archived text
a73a7f389796a1b14df010da20f9476c6b94b244d37f2d0d78a888019f3f59f2- Stable URL of this page
https://metraipolis.com/documento/dc_de674c8ee6f7
How to cite
Asparagine endopeptidase (AEP) inhibitor formulation via zein-based nanoparticle improves the therapeutic efficacy toward Alzheimer's disease — Europe PMC PMID:40816999 — Europe PMC (en), https://europepmc.org/article/MED/40816999 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de674c8ee6f7 (Metraipolis archive dc_de674c8ee6f7, sha256 a73a7f389796a1b14df010da20f9476c6b94b244d37f2d0d78a888019f3f59f2)
BibTeX
@misc{dcde674c8ee6f7,
title = {Asparagine endopeptidase (AEP) inhibitor formulation via zein-based nanoparticle improves the therapeutic efficacy toward Alzheimer's disease — Europe PMC PMID:40816999},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40816999},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de674c8ee6f7; sha256 a73a7f389796a1b14df010da20f9476c6b94b244d37f2d0d78a888019f3f59f2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40816999. Agents can read the archived copy with the MCP tool read_document.